EYPT
Price
$11.60
Change
+$0.09 (+0.78%)
Updated
Aug 21 closing price
Capitalization
799.56M
68 days until earnings call
RXRX
Price
$4.78
Change
+$0.01 (+0.21%)
Updated
Aug 21 closing price
Capitalization
2.08B
75 days until earnings call
Interact to see
Advertisement

EYPT vs RXRX

Header iconEYPT vs RXRX Comparison
Open Charts EYPT vs RXRXBanner chart's image
EyePoint Pharmaceuticals
Price$11.60
Change+$0.09 (+0.78%)
Volume$528.06K
Capitalization799.56M
Recursion Pharmaceuticals
Price$4.78
Change+$0.01 (+0.21%)
Volume$14.6M
Capitalization2.08B
EYPT vs RXRX Comparison Chart in %
Loading...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EYPT vs. RXRX commentary
Aug 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EYPT is a Buy and RXRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 22, 2025
Stock price -- (EYPT: $11.60 vs. RXRX: $4.78)
Brand notoriety: EYPT and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EYPT: 72% vs. RXRX: 54%
Market capitalization -- EYPT: $799.56M vs. RXRX: $2.08B
EYPT [@Biotechnology] is valued at $799.56M. RXRX’s [@Biotechnology] market capitalization is $2.08B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EYPT’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 1 green FA rating(s).

  • EYPT’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, EYPT is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EYPT’s TA Score shows that 3 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • EYPT’s TA Score: 3 bullish, 3 bearish.
  • RXRX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, EYPT is a better buy in the short-term than RXRX.

Price Growth

EYPT (@Biotechnology) experienced а +6.91% price change this week, while RXRX (@Biotechnology) price change was -15.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.66%. For the same industry, the average monthly price growth was +23.52%, and the average quarterly price growth was +24.22%.

Reported Earning Dates

EYPT is expected to report earnings on Oct 29, 2025.

RXRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.08B) has a higher market cap than EYPT($800M). EYPT YTD gains are higher at: 55.705 vs. RXRX (-29.290). EYPT has higher annual earnings (EBITDA): -172.05M vs. RXRX (-583.64M). RXRX has more cash in the bank: 525M vs. EYPT (256M). EYPT has less debt than RXRX: EYPT (21.8M) vs RXRX (88.1M). RXRX has higher revenues than EYPT: RXRX (64.5M) vs EYPT (51.9M).
EYPTRXRXEYPT / RXRX
Capitalization800M2.08B39%
EBITDA-172.05M-583.64M29%
Gain YTD55.705-29.290-190%
P/E RatioN/AN/A-
Revenue51.9M64.5M80%
Total Cash256M525M49%
Total Debt21.8M88.1M25%
FUNDAMENTALS RATINGS
EYPT: Fundamental Ratings
EYPT
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
84
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
16
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EYPTRXRX
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 10 days ago
84%
Declines
ODDS (%)
Bearish Trend 16 days ago
88%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FQUAX21.19N/A
N/A
AMG River Road Large Cap Value Select N
PVMIX16.14N/A
N/A
Principal MidCap Value I Inst
FBLEX14.55N/A
N/A
Fidelity Series Stk Selec Lg Cp Val
DCSYX65.37-0.09
-0.14%
Davis Balanced Fund Y
EPSYX24.79-0.06
-0.24%
NYLI Epoch Global Equity Yield Class I